Industry Analysis & Industry Trends
After experiencing low export demand and severe pricing pressures over the past five years, the Generic Pharmaceutical Manufacturing industry has significant opportunities to grow in the five years to 2020. A new wave of patent expirations and the growing market for biosimilars are expected to spur demand for new industry products. The industry will likely expand to meet this demand, with new companies increasingly attracted to the industry's new markets and growing profit margins. However, research and development (R&D) costs will continue to limit profit growth and the threat of further provincial reimbursement cuts for generic pharmaceuticals remains high... purchase to read more
Industry Report - Industry SWOT Analysis Chapter
The Generic Pharmaceutical Manufacturing industry in Canada is in the growth stage of its life cycle. Industry value added (IVA), which measures an industry's contribution to the overall economy, is expected to grow at an annualized rate of 2.9%. Comparatively, Canadian GDP is anticipated to rise at an average annual rate of 1.9%.
A high degree of technological change characterizes the Generic Pharmaceutical Manufacturing industry in Canada; therefore, IBISWorld expects this high-tech environment to further contribute to industry growth in coming years... purchase to read more